Rapid Micro Biosystems (RPID) Total Liabilities (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Total Liabilities data on file, last reported at $42.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 110.42% year-over-year to $42.0 million; the trailing twelve-month figure through Mar 2026 stood at $42.0 million (up 110.42% YoY), and the FY2025 full-year result was $41.6 million, up 82.52% from the prior year.
• Total Liabilities grew to $42.0 million in Q1 2026, from $41.6 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $42.0 million in Q1 2026 to a low of $19.9 million in Q1 2025.
• A 5-year average of $25.7 million and a median of $22.5 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities sank 63.45% in 2022 and surged 110.42% in 2026, its largest moves.
• Tracing RPID's Total Liabilities over 5 years: stood at $26.5 million in 2022, then decreased by 3.84% to $25.5 million in 2023, then decreased by 10.39% to $22.8 million in 2024, then soared by 82.52% to $41.6 million in 2025, then increased by 0.77% to $42.0 million in 2026.
• Business Quant data shows RPID's Total Liabilities at $42.0 million in Q1 2026, $41.6 million in Q4 2025, and $40.1 million in Q3 2025.